These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 10476602)

  • 1. [Recommendations for cardiovascular assessment and risk reduction in diabetes--1999. Società Italiana di Diabetologia, the Diabetes and Atherosclerosis Study Group, Associazione Medici Diabetologi].
    Ceriello A; Boemi M; Cucinotta D; De Feo P; Gensini GF; Lala A; Manzato E; Rivellese A; Ruotolo G; Vannuzzo D; Zavaroni I
    Cardiologia; 1999 Aug; 44(8):751-8. PubMed ID: 10476602
    [No Abstract]   [Full Text] [Related]  

  • 2. Italian standards for diabetes mellitus 2007: executive summary : Diabete Italia, AMD Associazione Medici Diabetologi, SID Società Italiana di Diabetologia.
    De Micheli A
    Acta Diabetol; 2008 Mar; 45(2):107-27. PubMed ID: 18373060
    [No Abstract]   [Full Text] [Related]  

  • 3. [Type 2 diabetes mellitus and cardiovascular diseases: evaluation, treatment and prevention strategies].
    Mosseri MM; Fisman EZ; Tenenbaum A
    Harefuah; 2006 Feb; 145(2):141-6, 164. PubMed ID: 16509421
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of guidelines of the management of cardiovascular risk factors in diabetic patients with macrovascular disease.
    Kollias A; Xilomenos A; Ikonomopoulou K; Tolis A
    Int Angiol; 2010 Feb; 29(1):87-8. PubMed ID: 20224540
    [No Abstract]   [Full Text] [Related]  

  • 5. [The guidelines of the ANMCO-SIC-AIAC on the appropriate use of the methods of permanent cardiac electric stimulation. Associazione Nazionale Medici Cardiologi Ospedalieri-Società Italiana di Cardiologia-Associazione Italiana di Aritmologia e Cardiostimolazione].
    Zoni Berisso M; Bongiorni MG; Della Bella P; Proclemer A; Viani S
    Ital Heart J Suppl; 2000 Apr; 1(4):551-68. PubMed ID: 10832144
    [No Abstract]   [Full Text] [Related]  

  • 6. 2013 ESC/EASD guidelines on the management of diabetes and cardiovascular disease: established knowledge and evidence gaps.
    Paneni F
    Diab Vasc Dis Res; 2014 Jan; 11(1):5-10. PubMed ID: 24254974
    [No Abstract]   [Full Text] [Related]  

  • 7. [The organizational and technical aspects of transcatheter ablation in cardiac arrhythmias. A document of the Gruppo Italiano di Aritmologia with a contribution of the Assoziazione Italiana di Cardiostimolazione under the aegis of the Società Italiana di Cardiologia and of the Associazione Nazionale Medici Cardiologi Ospedalieri].
    Cardiologia; 1995 Aug; 40(8):593-609. PubMed ID: 8536286
    [No Abstract]   [Full Text] [Related]  

  • 8. [The biochemical markers of myocardial damage. The Intersociety Interdisciplinary Study Group of the ANMCO-SIBioC-SIMeL, Markers of Myocardial Lesions. Associazione Nazionale Medici Cardiologi Ospedalieri-SIBioC-Società Italiana di Medicina di Laboratorio].
    Dolci A; Vernocchi A; Zaninotto M; Galvani M; Ottani F; Tubaro M; Plebani M; Panteghini M
    G Ital Cardiol; 1999 Jun; 29(6):739-47. PubMed ID: 10396682
    [No Abstract]   [Full Text] [Related]  

  • 9. Management of metabolic adverse events of targeted therapies and immune checkpoint inhibitors in cancer patients: an Associazione Italiana Oncologia Medica (AIOM)/Associazione Medici Diabetologi (AMD)/Società Italiana Farmacologia (SIF) multidisciplinary consensus position paper.
    Silvestris N; Argentiero A; Beretta GD; Di Bartolo P; Montagnani M; Danesi R; Ferrari P; D'Oronzo S; Gori S; Russo A; Acquati S; Gallo M
    Crit Rev Oncol Hematol; 2020 Oct; 154():103066. PubMed ID: 32853883
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patterns of care an Italian diabetic population. The Italian Study Group for the Implementation of the St Vincent Declaration, Società Italiana di Diabetologia, Associazione Medici Diabetologi.
    Nicolucci A; Scorpiglione N; Belfiglio M; Carinci F; Cavaliere D; el-Shazly M; Labbrozzi D; Mari E; Massi Benedetti M; Tognoni G
    Diabet Med; 1997 Feb; 14(2):158-66. PubMed ID: 9047095
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antineoplastic dosing in overweight and obese cancer patients: an Associazione Italiana Oncologia Medica (AIOM)/Associazione Medici Diabetologi (AMD)/Società Italiana Endocrinologia (SIE)/Società Italiana Farmacologia (SIF) multidisciplinary consensus position paper.
    Silvestris N; Argentiero A; Natalicchio A; D'Oronzo S; Beretta GD; Acquati S; Adinolfi V; Di Bartolo P; Danesi R; Faggiano A; Ferrari P; Gallo M; Gori S; Morviducci L; Russo A; Tuveri E; Zatelli MC; Montagnani M; Giorgino F
    ESMO Open; 2021 Jun; 6(3):100153. PubMed ID: 33984679
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Primary prevention of cardiovascular diseases in people with diabetes mellitus: a scientific statement from the American Heart Association and the American Diabetes Association.
    Buse JB; Ginsberg HN; Bakris GL; Clark NG; Costa F; Eckel R; Fonseca V; Gerstein HC; Grundy S; Nesto RW; Pignone MP; Plutzky J; Porte D; Redberg R; Stitzel KF; Stone NJ; ;
    Diabetes Care; 2007 Jan; 30(1):162-72. PubMed ID: 17192355
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preventing cardiovascular diseases in people with diabetes.
    Gerstein HC
    Can J Cardiol; 1999 Dec; 15 Suppl G():65G-8G. PubMed ID: 10722308
    [No Abstract]   [Full Text] [Related]  

  • 14. ESC guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD - summary.
    ; ; Rydén L; Grant PJ; Anker SD; Berne C; Cosentino F; Danchin N; Deaton C; Escaned J; Hammes HP; Huikuri H; Marre M; Marx N; Mellbin L; Ostergren J; Patrono C; Seferovic P; Uva MS; Taskinen MR; Tendera M; Tuomilehto J; Valensi P; Zamorano JL
    Diab Vasc Dis Res; 2014 May; 11(3):133-73. PubMed ID: 24800783
    [No Abstract]   [Full Text] [Related]  

  • 15. [The effect of metformin on late diabetic complications and cardiovascular events in obese patients with type 2 diabetes].
    Christiansen AL; Madsbad S
    Ugeskr Laeger; 2002 Apr; 164(15):2022-4. PubMed ID: 11984999
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Primary prevention of cardiovascular disease in people with dysglycemia.
    Bianchi C; Miccoli R; Penno G; Del Prato S
    Diabetes Care; 2008 Feb; 31 Suppl 2():S208-14. PubMed ID: 18227487
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-inflammatory Strategies to Prevent Diabetic Cardiovascular Disease.
    Jialal I; Devaraj S
    Clin Pharmacol Ther; 2015 Aug; 98(2):121-3. PubMed ID: 25732108
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [How does the PROactive Study change therapy of diabetes?].
    Erdmann E
    MMW Fortschr Med; 2005 Oct; 147(41):6. PubMed ID: 16270501
    [No Abstract]   [Full Text] [Related]  

  • 19. [The role of biochemical markers of myocardial damage in clinical practice: the diagnosis of infarct and risk stratification. The Intersociety Interdisciplinary Study Group of the ANMCO-SIBioC-SIMeL, Markers of Muocardial Lesions. L'Associazione Nazionale Medici Cardiologi Ospedalieri-Società Italiana di Biochimica Clinica-Società Italiana di Medicina di Laboratorio].
    Ottani F; Galvani M; Panteghini M; Dolci A; Plebani M; Tubaro M; Zaninotto M
    Ital Heart J Suppl; 2000 Jan; 1(1):54-64. PubMed ID: 10832120
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of oral anti-diabetic agents in modifying cardiovascular risk factors.
    Shin JJ; Rothman J; Farag A; McFarlane SI; Sowers JR
    Minerva Med; 2003 Dec; 94(6):401-8. PubMed ID: 14976468
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.